D006220Chemicals & DrugsD02.522.352.5065310.989611HaloperidolFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson30346241Bleck TPThe New England journal of medicineDopamine Antagonists in ICU Delirium. N Engl J Med. 2018 12 27; 379(26):2569-2570.N Engl J Med2018-10-22T00:00:002018Dopamine Antagonists in ICU Delirium.true1ProfessorProfessorRobertBalkRobert A. Balk349167Balk, RobertProfessorThomasBleckThomas Bleck349180Bleck, ThomasProfessorPaulCarveyPaul Carvey41.87432800000000-87.67059170000000349203Carvey, PaulProfessorKathleenDelaneyKathleen Delaney41.87360160000000-87.66953150000000349552Delaney, KathleenProfessorChristopherGoetzChristopher Goetz349622Goetz, ChristopherProfessor4Professor12522522Hassaballa HA, Balk RAAmerican journal of therapeuticsTorsade de pointes associated with the administration of intravenous haloperidol. Am J Ther. 2003 Jan-Feb; 10(1):58-60.Am J Ther2003-01-01T00:00:002003Torsade de pointes associated with the administration of intravenous haloperidol.14585064Hassaballa HA, Balk RAExpert opinion on drug safetyTorsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use. Expert Opin Drug Saf. 2003 Nov; 2(6):543-7.Expert Opin Drug Saf2003-11-01T00:00:002003Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.0.6818470.06747985research area of0.6861220.011577122subject area forNeurological SciencesRush University, College of NursingRush University, Rush Medical CollegeCommunity, Systems and Mental Health Nursingtrue1ProfessorProfessor1335837Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PMClinical neuropharmacologySynaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol. 1992 Dec; 15(6):488-500.Clin Neuropharmacol1992-12-01T00:00:001992Synaptic plasticity in the rat striatum following chronic haloperidol treatment.2209714Carvey PM, Nath ST, Kao LC, Zhang TJ, Lin DH, Singh R, Amdur RL, Klawans HLEuropean journal of pharmacologyClozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. Eur J Pharmacol. 1990 Aug 02; 184(1):43-53.Eur J Pharmacol1990-08-02T00:00:001990Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.true1ProfessorProfessortrue1ProfessorProfessorInternal Medicine, Division of Pulmonary Disease Critical CarePhysiology and Biophysicstrue1ProfessorProfessor